MiNK Therapeutics
INKT
trading on NASDAQ
since 2021
$44.90
(Δ -31.98%)
-$20.52 since open
MiNK Therapeutics is a biotechnology company focused on developing innovative antibody-based cancer treatments targeting solid tumors.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $21.07 | $76.00 | $20.20 | $27.94M | 47.86M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$0.70 | n/a | 13170.65 | -19979.93% | -20468.28% | 0% |